Search Results - Lena Schultz
- Showing 1 - 2 results of 2
-
1
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies by Peter Ellmark, Jeffrey Yachnin, Ana Carneiro, Lena Schultz, Amanda Hahn, Sumeet Ambarkhane, Karin Enell Smith, Gustav J. Ullenhag
Published in Journal for ImmunoTherapy of Cancer (2025-01-01)Get full text
Article -
2
Rehabilitation and Return-to-Work of Patients Acquiring COVID-19 in the Workplace: A Study Protocol for an Observational Cohort Study by Katrin Müller, Katharina Zwingmann, Tina Auerswald, Ivo Berger, Andreas Thomas, Anna-Lena Schultz, Eva Wilhelm, Rainer-Christian Weber, Franziska Kolb, Alois Wastlhuber, Sylvia Meder, Michael Stegbauer
Published in Frontiers in Rehabilitation Sciences (2022-01-01)Get full text
Article
